These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. It's all about cures and cash. How the winner of the race to patent human genes may strike it rich. Sherrid P US News World Rep; 2001 Jan; 130(1):35-6. PubMed ID: 11189705 [No Abstract] [Full Text] [Related]
11. Biotechs sue Columbia over fourth Axel patent. Howard K Nat Biotechnol; 2003 Sep; 21(9):955-6. PubMed ID: 12949538 [No Abstract] [Full Text] [Related]
12. Equivalents in biotechnology patents. Auer HE Nat Biotechnol; 2003 Mar; 21(3):329-31. PubMed ID: 12610574 [No Abstract] [Full Text] [Related]
18. The scope of utility in the twenty-first century: new guidance for gene-related patents. Summers TM Georgetown Law J; 2003 Jan; 91(2):475-509. PubMed ID: 15046071 [No Abstract] [Full Text] [Related]
19. The coming US patent opposition. Apple T Nat Biotechnol; 2005 Feb; 23(2):245-7. PubMed ID: 15696151 [No Abstract] [Full Text] [Related]
20. The new section 103(b) of the patent law: an obvious solution? Van Horn CE; Barlow SA Nat Biotechnol; 1996 Jun; 14(6):773-4. PubMed ID: 9630989 [No Abstract] [Full Text] [Related] [Next] [New Search]